Vertex Pharmaceuticals Incorporated (VRTX) Revenue Growth
Vertex Pharmaceuticals Incorporated (VRTX) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 46.20% |
| 2018-12-31 | 22.46% |
| 2019-12-31 | 36.59% |
| 2020-12-31 | 49.07% |
| 2021-12-31 | 22.06% |
| 2022-12-31 | 17.91% |
| 2023-12-31 | 10.51% |
| 2024-12-31 | 11.66% |
| 2025-12-31 | 8.90% |
How VRTX compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| AMGN | Amgen Inc. | 9.95% |
| UHS | Universal Health Services Inc. | 9.71% |
| STE | STERIS plc (Ireland) | 8.73% |
| MDT | Medtronic plc. | 8.43% |
| CVS | CVS Health Corporation | 7.85% |
These are five companies in the same sector as VRTX with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("VRTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VRTX | $544.52 | +0.52% | 1.20M |
| 3 | ||||
| 4 | ||||
| 5 |